Dr. Toneguzzo is the Executive Vice President, New Product Planning & Strategy for NantKwest, a clinical-stage immunotherapy company focused on harnessing the unique power of the immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. Prior to this, Frances served as the Director of Corporate Sponsored Research & Licensing at Partners Healthcare, where her team oversaw the management and licensing of intellectual property and served as the entry point for all industrial relationships relating to research, support of research or technology transfer. Prior to coming to Partners, Dr. Toneguzzo served as Director of the Office for Technology and Industry Collaboration at Tufts University/New England Medical Center and as Associate Director, responsible for intellectual property relating to the life sciences at Harvard University. Her additional experience in the biotech industry includes technical and business development roles at big pharma (E. I Dupont & Co) as well as mid-sized (E.G.&G.Biomolecular) and startup companies (One Cell Systems). She holds a Ph.D. in Biochemistry from McMaster University in Canada.